Herbs and plantsTurmeric stronger than ibuprofen?
- Henryk Różański — Wyciąg z kurkumy w praktycznej fitoterapii.
- Henryk Różański — Kurkuma – ostryż – Curcuma
- Henryk Różański — Acidum gallicum – kwas galusowy jako lek w dawnej medycynie
- Efficacy and safety of different curcumin formulations in osteoarthritis: an umbrella review of systematic reviews. · Front Med (Lausanne) 2026
- Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. · Clin Interv Aging 2014
- Efficacy and safety of Curcuma domestica extracts in patients with knee osteoarthritis. · J Altern Complement Med 2009
Henryk Różański says that curcumin inhibits prostaglandin synthesis, but this does not mean that turmeric is stronger than ibuprofen.
- He also writes that turmeric extract has anti-inflammatory effects, and that turmeric inhibits prostaglandin synthesis and acts as a lipoxygenase inhibitor.
- Gallic acid enhances ibuprofen’s anti-inflammatory effects and is described as synergistic with curcumin and turmeric, but this does not prove that turmeric is superior to ibuprofen.
What the authors write
Turmeric extract has anti-inflammatory effects.
Turmeric inhibits prostaglandin synthesis and acts as a lipoxygenase inhibitor.
Curcumin inhibits prostaglandin synthesis and acts as a lipoxygenase inhibitor.
Gallic acid enhances ibuprofen’s anti-inflammatory effects.
Gallic acid is described as synergistic with curcumin and turmeric.
Research from PubMed · Europe PMC
We selected 3 studies with the best, positive results. This is a selection, not a full review of all research.
Total number of studies on this topic in PubMed: 20.
A review found that curcumin preparations may relieve pain and improve joint function in osteoarthritis, with results comparable to NSAIDs, although the evidence is inconsistent.
Aim of the study: This umbrella review synthesizes evidence from systematic reviews and meta-analyses evaluating the efficacy and safety of diverse curcumin formulations in the treatment of osteoarthritis (OA). The objective is to assess curcumin's therapeutic potential and inform future formulation development.
Results: Ten meta-analyses and systematic reviews were included. Curcumin formulations exhibited significant improvements in pain (VAS) and joint function/stiffness (WOMAC), showing efficacy signals comparable to non-steroidal anti-inflammatory drugs (NSAIDs) and a more favorable tolerability profile in the available studies. However, methodological and clinical heterogeneity was substantial (AMSTAR-2 rated only three studies as high quality). Variations in curcumin composition, bioavailability-enhancing strategies, and extraction methods, coupled with the absence of direct comparative analyses among formulations, precluded definitive inter-group comparisons. Curcumin-based interventions show promise for OA symptom management, with efficacy signals comparable to NSAIDs and appear to have a more favorable tolerability profile in the available studies, while addressing bioavailability challenges.
“Not stated” does not mean nobody paid — the database does not always record it.
In people with knee osteoarthritis, turmeric extract improved pain and function similarly to ibuprofen, while abdominal complaints were more common with ibuprofen.
Aim of the study: To determine the efficacy and safety of Curcuma domestica extracts in pain reduction and functional improvement.
Results: 185 and 182 patients were randomly assigned into C. domestica extracts and ibuprofen groups, respectively. The baseline characteristics were no different between groups. The mean of all WOMAC scores at weeks 0, 2, and 4 showed significant improvement when compared with the baseline in both groups. After using the noninferiority test, the mean difference (95% confidence interval) of WOMAC total, WOMAC pain, and WOMAC function scores at week 4 adjusted by values at week 0 of C. domestica extracts were noninferior to those for the ibuprofen group (P=0.010, P=0.018, and P=0.010, respectively), except for the WOMAC stiffness subscale, which showed a trend toward significance (P=0.060). The number of patients who developed AEs was no different between groups. However, the number of events of abdominal pain/discomfort was significantly higher in the ibuprofen group than that in the C. domestica extracts group (P=0.046).
“Not stated” does not mean nobody paid — the database does not always record it.
In a study of people with knee osteoarthritis, turmeric extract led to similar improvements to ibuprofen in most of the symptoms and functions assessed.
Aim of the study: The objective of this study was to determine the efficacy and safety of Curcuma domestica extracts in pain reduction and functional improvement in patients with knee osteoarthritis.
Results: Fifty-two (52) and 55 patients were randomized to C. domestica extracts and ibuprofen groups, respectively. Baseline characteristics of the patients in both groups were not different. The mean scores of the aforementioned outcomes at weeks 0, 2, 4, and 6 were significantly improved when compared with the baseline values in both groups. There was no difference in those parameters between the patients receiving ibuprofen and C. domestica extracts, except pain on stairs (p = 0.016). No significant difference of adverse events between both groups was found (33.3% versus 44.2%, p = 0.36 in C. domestica extracts and ibuprofen groups, respectively). C. domestica extracts seem to be similarly efficacious and safe as ibuprofen for the treatment of knee OA.
“Not stated” does not mean nobody paid — the database does not always record it.
Pisaczek does not judge who is right. It shows what was written and where to read it. Every sentence above has its source.